Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/ENHERTU-fam-trastuzumab-deruxtecan-nxki-improved-PFS-in-HER2-low-and-ultralow-46562986/?utm_source=whatsapp&utm_medium=social&utm_campaign=share